Herbalife price target raised to $8 from $7 at BofA

BofA raised the firm’s price target on Herbalife (HLF) to $8 from $7 and keeps an Underperform rating on the shares. Entering 2026, the largest unresolved question for staples remains consumption growth and valuations remain dispersed across the group, but “there feels little to get them off the sidelines in ’26 until fundamentals signal a greater turning of the tide,” the analyst tells investors in a year-ahead note for the consumer staples group.